Skip to main content
. 2009 Aug 7;15(29):3636–3642. doi: 10.3748/wjg.15.3636

Table 2.

Reason for dropout in both study groups n (%)

Imipramine (n = 59) Placebo (n = 48) P-value
Total dropouts 28 (47.5) 23 (47.9) NS
Premature withdrawal 8 (13.6) 14 (29.2) < 0.05
Lost to follow-up 3 (5.1) 3 (6.3) NS
Protocol violation 3 0 NS
Side effects 14 (23.7) 6 (12.5) 0.094

NS: Not significant.